CLINICAL_TRIALS ClinicalTrials.gov record update

A 12-month Real Life Study of IBD Patients Under Stable Steroid Free Clinical and Biological Remission Switched From Adalimumab Originator Humira® to One of Its Biosimilar: Amgevita®,Hulio®,Hyrimoz® or Imraldi®.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04422171
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:00.668519+00:00
Published At: 2020-09-29T00:00:00+00:00
Record Updated At: 2020-09-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["IBD Patients, Originator Treatment, Biosimilar, Switch Back"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-09-29"
protocolSection.identificationModule.nctId: "NCT04422171"
protocolSection.identificationModule.officialTitle: "A 12-month Real Life Study of IBD Patients Under Stable Steroid Free Clinical and Biological Remission Switched From Adalimumab Originator Humira\u00ae to One of Its Biosimilar: Amgevita\u00ae,Hulio\u00ae,Hyrimoz\u00ae or Imraldi\u00ae."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.